Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.480
-0.020 (-0.57%)
May 11, 2026, 4:00 PM EDT - Market closed

ADC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4434441971373101,552
Market Cap Growth
235.56%125.63%44.02%-55.89%-80.04%-36.82%
Enterprise Value
647.88296.0467.49-19.0887.031,099
Last Close Price
3.483.531.991.663.8420.20
PE Ratio
--3.15-1.23-0.56-1.91-6.73
PS Ratio
5.595.462.781.961.4845.75
PB Ratio
--2.39-0.97-0.923.499.34
P/TBV Ratio
-2.23-2.41-0.95-0.913.389.33
P/FCF Ratio
--3.14-1.58-1.12-2.23-6.55
P/OCF Ratio
--3.14-1.59-1.15-2.24-6.65
EV/Sales Ratio
8.183.640.95-0.270.4132.39
EV/EBITDA Ratio
--2.47-0.530.12-0.72-4.24
EV/EBIT Ratio
--2.44-0.520.11-0.71-4.20
EV/FCF Ratio
--2.09-0.540.16-0.63-4.64
Debt / Equity Ratio
-0.52-0.61-0.60-0.831.170.08
Debt / EBITDA Ratio
-1.00-0.97-0.95-0.75-0.97-0.06
Debt / FCF Ratio
-1.02-0.82-0.97-1.01-0.84-0.06
Net Debt / Equity Ratio
0.530.780.641.05-2.36-2.72
Net Debt / EBITDA Ratio
0.981.211.010.961.731.74
Net Debt / FCF Ratio
1.001.021.041.281.501.91
Asset Turnover
0.260.250.210.160.370.06
Inventory Turnover
1.641.800.650.150.220.25
Quick Ratio
3.874.143.374.494.046.72
Current Ratio
4.094.373.624.974.517.10
Return on Equity (ROE)
68.12%73.43%89.09%788.03%-115.41%-100.28%
Return on Assets (ROA)
-38.73%-37.94%-38.65%-45.07%-21.54%-46.25%
Return on Invested Capital (ROIC)
3030.00%1664.10%31067.20%-200.31%-75.80%-255.76%
Return on Capital Employed (ROCE)
-49.61%-49.14%-49.43%-46.28%-25.32%-51.45%
Earnings Yield
-30.95%-31.73%-81.41%-177.11%-52.34%-14.85%
FCF Yield
-25.89%-31.86%-63.39%-89.24%-44.89%-15.26%
Buyback Yield / Dilution
-23.08%-30.78%-18.91%-4.55%-1.83%-17.33%
Total Shareholder Return
-23.08%-30.78%-18.91%-4.55%-1.83%-17.33%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q